Education
About Us
Working with TipRanks
Follow Us
Hexima Ltd (AU:HXL)
:HXL
HXL Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.02
Previous CloseN/A
Volume15.80K
Average Volume (3M)0.00
Market Cap
AU$2.17M
Enterprise ValueAU$530.28K
Total Cash (Recent Filing)AU$1.91M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-1.67
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding167,039,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Hexima Ltd News
PremiumCompany Announcements
Hexima Limited Reports Increased Losses and Decline in Net Tangible Assets
PremiumCompany Announcements
Hexima Ltd Withdraws from AI Acquisition, Focuses on Biotech Opportunities
PremiumCompany Announcements
Hexima Ltd Announces Cessation of Securities Options
PremiumCompany Announcements
Hexima Ltd Cancels Securities Issuance PlanPremiumCompany Announcements
Hexima Ltd Cancels Share Issue Plans
PremiumCompany Announcements
Hexima Ltd Cancels Acquisition, Explores New Opportunities
PremiumCompany Announcements
Hexima Ltd Sees Strong Shareholder Support at AGM
PremiumCompany Announcements
Hexima Limited Pursues Strategic Acquisition Amidst Financial Update---
HXL FAQ
What was Hexima Ltd’s price range in the past 12 months?
Hexima Ltd lowest share price was <AU$0.01 and its highest was AU$0.02 in the past 12 months.
What is Hexima Ltd’s market cap?
Hexima Ltd’s market cap is AU$2.17M.
When is Hexima Ltd’s upcoming earnings report date?
Hexima Ltd’s upcoming earnings report date is Aug 28, 2025 which is in 146 days.
How were Hexima Ltd’s earnings last quarter?
Hexima Ltd released its earnings results on Feb 28, 2025. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Hexima Ltd overvalued?
According to Wall Street analysts Hexima Ltd’s price is currently Overvalued.
Does Hexima Ltd pay dividends?
Hexima Ltd does not currently pay dividends.
What is Hexima Ltd’s EPS estimate?
Hexima Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hexima Ltd have?
Hexima Ltd has 167,039,630 shares outstanding.
What happened to Hexima Ltd’s price movement after its last earnings report?
Hexima Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hexima Ltd?
Currently, no hedge funds are holding shares in AU:HXL
---
Hexima Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:HXL Sentiment 70%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.33%
12-Months-Change
Fundamentals
Return on Equity
-45.96%
Trailing 12-Months
Asset Growth
-36.78%
Trailing 12-Months
Company Description
Hexima Ltd
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.
---
HXL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Biotron Limited
―
PYC Therapeutics Limited
―
Proteomics International Laboratories Ltd.
―
---